These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 812944)

  • 21. Comparative study on R-type pyocins of Pseudomonas aeruginosa.
    Ohsumi M; Shinomiya T; Kageyama M
    J Biochem; 1980 Apr; 87(4):1119-25. PubMed ID: 6771248
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Release of lipopolysaccharide during the preparation of cell walls of Pseudomonas aeruginosa.
    Roberts NA; Gray GW; Wilkinson SG
    Biochim Biophys Acta; 1967; 135(5):1068-71. PubMed ID: 4965163
    [No Abstract]   [Full Text] [Related]  

  • 23. Studies on the bacteriophage 2 receptors of Pseudomonas aeruginosa.
    Castillo FJ; Bartell PF
    J Virol; 1974 Oct; 14(4):904-9. PubMed ID: 4213969
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amino components of the lipopolysaccharide from Pseudomonas aeruginosa N.C.T.C. 8505. Presence of 2,4-diamino-2,4,6-trideoxy-D-glucose.
    Wilkinson SG
    Biochem J; 1977 Jan; 161(1):103-9. PubMed ID: 403906
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pseudomonas aeruginosa hospital infection in a pediatric unit. Typing by pyocine production].
    Fernandez H; Lembke C
    Rev Chil Pediatr; 1975; 46(1):81-4. PubMed ID: 809813
    [No Abstract]   [Full Text] [Related]  

  • 26. The chemical composition of the lipopolysaccharide from Pseudomonas aeruginosa strain PAO and a spontaneously derived rough mutant.
    Jarrell K; Kropinski AM
    Microbios; 1977; 19(76):103-16. PubMed ID: 104126
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pyocine typing and drug resistance of Pseudomonas aeruginosa.
    Turano A; Peretti P
    J Antimicrob Chemother; 1977 Nov; 3 Suppl C():43-5. PubMed ID: 413824
    [No Abstract]   [Full Text] [Related]  

  • 28. Study of 32 new phage tail-like bacteriocins (pyocins) from a clinical collection of Pseudomonas aeruginosa and of their potential use as typing markers and antimicrobial agents.
    Blasco L; de Aledo MG; Ortiz-Cartagena C; Blériot I; Pacios O; López M; Fernández-García L; Barrio-Pujante A; Hernández-Garcia M; Cantón R; Tomás M
    Sci Rep; 2023 Jan; 13(1):117. PubMed ID: 36596850
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunochemical studies of the lipopolysaccharides of "serotype 145-46" (Enterbacteriaceae).
    Tekelieva R
    Zentralbl Bakteriol Orig A; 1975; 231(1-3):92-6. PubMed ID: 1154919
    [No Abstract]   [Full Text] [Related]  

  • 30. Studies on the pyocins of Pseudomonas aeruginosa: morphology and mode of action of contractile pyocins.
    Govan JR
    J Gen Microbiol; 1974 Jan; 80(1):1-15. PubMed ID: 4206804
    [No Abstract]   [Full Text] [Related]  

  • 31. Pyocin sensitivity of Pseudomonas species.
    Jones LF; Thomas ET; Stinnett JD; Gilardi GL; Farmer JJ
    Appl Microbiol; 1974 Jan; 27(1):288-9. PubMed ID: 4203785
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Direct evidence for the presence of lipopolysaccharide components in Pseudomonas ribosomal vaccine.
    Lieberman MM
    Infect Immun; 1977 Aug; 17(2):471-3. PubMed ID: 408275
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amino sugars in the wall of Pseudomonas fluorescens.
    Wilkinson SG
    J Gen Microbiol; 1972 Apr; 70(2):365-9. PubMed ID: 4624992
    [No Abstract]   [Full Text] [Related]  

  • 34. [Lipopolysaccharides from Rhodospirillaceae: composition and taxonomic relevance].
    Weckesser J; Drews G; Mayer H; Fromme I
    Zentralbl Bakteriol Orig A; 1974; 228(1):193-8. PubMed ID: 4154665
    [No Abstract]   [Full Text] [Related]  

  • 35. Immunochemical and toxic properties of the lipopolysaccharides from highly and low virulent Pseudomonas aeruginosa strains.
    Mlynarcík D; Muszyński Z
    J Hyg Epidemiol Microbiol Immunol; 1974; 18(4):425-8. PubMed ID: 4217813
    [No Abstract]   [Full Text] [Related]  

  • 36. Studies of lipopolysaccharides from Pseudomonas aeruginosa.
    Wilkinson SG; Galbrath L
    Eur J Biochem; 1975 Mar; 52(2):331-43. PubMed ID: 809266
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Studies on the host range specificity of pyocin P1.
    Brandis H; Krämer J; Israil A
    Arch Roum Pathol Exp Microbiol; 1975; 34(1-2):13-20. PubMed ID: 813612
    [No Abstract]   [Full Text] [Related]  

  • 38. Aeruginocin tolerant mutants of Pseudomonas aeruginosa.
    Holloway BW; Rossiter H; Burgess D; Dodge J
    Genet Res; 1973 Dec; 22(3):239-53. PubMed ID: 4209245
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of iron concentration in the growth medium on the sensitivity of Pseudomonas aeruginosa to pyocin S2.
    Ohkawa I; Shiga S; Kageyama M
    J Biochem; 1980 Jan; 87(1):323-31. PubMed ID: 6766926
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Typing of non-serogroupable Neisseria meningitidis by means of sensitivity to R-type pyocines of Pseudomonas aeruginosa.
    Blackwell CC; Law JA
    J Infect; 1981 Dec; 3(4):370-8. PubMed ID: 6821098
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.